Immunology research is integral to our understanding of the immune system and its role in health and disease. The range of immunology research tools that we provide at Caltag Medsystems can be used in diverse immunology-related projects such as: At
The invaluable role of QuickSwitch™ kits in validating predicted results
Wang, Wenfeng, et al 2023, selected the top 15 top peptides for self-antigen for their study. By using the QuickSwitch™ kit, they successfully switched 6 peptides to the tetramer complex with an efficiency of over 75%.
Ensure Accurate Immune Monitoring Results with Negative Controls
Negative controls aid precision of immune response monitoring. For HLA-A*02:01 alleles, MBLI offers a “Negative Tetramer” in BV421, PE or APC.
Validation of Neoantigen In Silico Prediction using QuickSwitch™ Kits
Research findings indicate that neoantigens have the potential to activate tumour-specific T-cell-mediated anti-tumour immune responses.
Drug Discovery Tools by Caltag Medsystems
At Caltag Medsystems, you will be able to find a wide range of tools to help with your drug discovery project. See the range here.
Cancer Immunotherapy: An increasing emphasis on CD4+ T cells and MHC Class II Neoantigens
QuickSwitch™ Class II Tetramer Peptide Exchange and Quantitation Kit utilises a patented technique for exchanging up to ten peptides on an MHC Class II Tetramer.
SARS-CoV-2 Open Reading Frames (ORFs)
The SARS-CoV-2 genome is ~29 kb divided into 10 ORFs. Each of these ORFs (except seemingly ORF10) is translated in 29 different proteins.
Correlation Between HLA Typing and Immune Monitoring in Human Disease
The human leukocyte antigen system, aka human major histocompatibility complex, was named after its discovery with alloantibodies against leukocytes.
Non-classical MHCs mediate activation or inhibition in natural killer (NK) cells: HLA-E, Qa-1b, and MR1
MBL International offers tetramers for the following non-classical MHC targets: HLA-E, Qa-1b, and MR1.
Validated Recombinant Proteins for ACE2 & COVID-19 Research
List of AdipoGen Life Sciences’ validated recombinant proteins for ACE2 & COVID-19 research